Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cell
Therapeutic Area : Orthopedics/Orthopedic Surgery
Study Phase : Phase III
Sponsor : Medipost
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM®) for Osteochondral Lesion of Talus
Details : Undisclosed
Product Name : Cartistem
Product Type : Cell and Gene therapy
Upfront Cash : Inapplicable
March 17, 2020
Lead Product(s) : Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cell
Therapeutic Area : Orthopedics/Orthopedic Surgery
Highest Development Status : Phase III
Sponsor : Medipost
Deal Size : Inapplicable
Deal Type : Inapplicable